Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer's Disease: A Translational Overview

P. R. A. Heckman; C. Wouters; J. Prickaerts

doi:10.2174/1381612820666140826114601

Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer's Disease: A Translational Overview

P. R. A. Heckman, C. Wouters, J. Prickaerts

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	317-331
Journal	Current Pharmaceutical Design
Volume	21
Issue number	3
DOIs	https://doi.org/10.2174/1381612820666140826114601
Publication status	Published - 2015

Keywords

cAMP
cGMP
dementia
long-term potentiation
neurogenesis
PDE
rolipram
sildenafil

Access to Document

10.2174/1381612820666140826114601

Cite this

Heckman, P. R. A., Wouters, C., & Prickaerts, J. (2015). Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer's Disease: A Translational Overview. Current Pharmaceutical Design, 21(3), 317-331. https://doi.org/10.2174/1381612820666140826114601

@article{8bfd8a87fcfb4469b7e6c43eece32079,

title = "Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer's Disease: A Translational Overview",

keywords = "cAMP, cGMP, dementia, long-term potentiation, neurogenesis, PDE, rolipram, sildenafil",

author = "Heckman, {P. R. A.} and C. Wouters and J. Prickaerts",

year = "2015",

doi = "10.2174/1381612820666140826114601",

language = "English",

volume = "21",

pages = "317--331",

journal = "Current Pharmaceutical Design",

issn = "1381-6128",

publisher = "Bentham Science Publishers Ltd.",

number = "3",

}

TY - JOUR

T1 - Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer's Disease: A Translational Overview

AU - Heckman, P. R. A.

AU - Wouters, C.

AU - Prickaerts, J.

PY - 2015

Y1 - 2015

KW - cAMP

KW - cGMP

KW - dementia

KW - long-term potentiation

KW - neurogenesis

KW - PDE

KW - rolipram

KW - sildenafil

U2 - 10.2174/1381612820666140826114601

DO - 10.2174/1381612820666140826114601

M3 - Article

VL - 21

SP - 317

EP - 331

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 3

ER -